In 2018, sales of insulins at the ex-manufacturer price level were almost $14 billion across the major markets (United States, EU5, and Japan).  Throughout our 2018-2028 forecast period, more originator insulins manufactured by Eli Lilly, Novo Nordisk, and Sanofi are set for increasing competition from insulin biosimilars across the major markets, eroding both patient share and drug prices. We present our forecasts for key reference brand insulins and their biosimilars by therapeutic area, molecule, and region.

Table of contents

  • Endocrinology
    • Market Forecast in the Major Pharmaceutical Markets
      • Terminology
    • Overarching Forecast Assumptions
      • Overview of Insulin Brands in Forecast
        • Biosimilar Entry Assumptions for Approved Insulins
      • Overview of Insulin Biosimilar Assumptions
    • Drug-Specific Forecast Assumptions
      • Lantus
        • Forecast Assumptions
        • Market Forecast: Lantus
      • Levemir
        • Forecast Assumptions
        • Market Forecast: Levemir
      • Humalog / Humalog Mix
        • Forecast Assumptions
        • Market Forecast: Humalog / Humalog Mix
      • NovoLog / NovoRapid and NovoMix
        • Forecast Assumptions
        • Market Forecast: NovoLog / NovoRapid
        • Market Forecast: NovoMix

Author(s): Hamzah Aideed, MSc

Hamzah Aideed is a Principal Analyst in the biosimilars team at Decision Resources Group. Hamzah’s responsibilities include conducting primary and secondary market research, generating key insights into biosimilars and the biopharmaceutical industry, and providing client support. His work in biosimilars encompasses four key therapy areas – immunology, oncology, endocrinology, and nephrology. Prior to joining DRG, Hamzah was a Senior Research Executive at Consulting at McCann Health, specializing in the design and execution of advanced qualitative and quantitative research methodologies, for bespoke ad-hoc consulting projects. He holds an in Biotechnology & Business Management from the University of Warwick and a in Biological Chemistry from Aston University.